Aspergillus fumigatus tricuspid native valve endocarditis in a non-intravenous drug user

References

1. Abgueguen P., Gouello J. P., Pichard E., Chabasse D., Donal E., Alquier P. 2002; Candida endocarditis: retrospective study in 12 patients. Rev Med Interne 23:30–40 (in French [CrossRef]
   [Google Scholar]
2. Bayer A. S., Scheld M. 2000; Endocarditis and intravascular infections. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases . , 5th edn. vol 1 pp  857–902 Edited by Mandell G. L., Bennett J. E., Dolin R. Philadelphia, PA: Churchill Livingstone;
3. Chandrasekar P. H., Cutright J. L., Manavathu E. K. 2001; Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents. Diagn Microbiol Infect Dis 41:211–214 [CrossRef]
   [Google Scholar]
4. Karchmer A. W. 2000; Infections of prosthetic valves and intravascular devices. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases . , 5th edn. vol 1 pp  903–917 Edited by Mandell G. L., Bennett J. E., Dolin R. Philadelphia, PA: Churchill Livingstone;
5. Li J. S., Sexton D. J., Mick N., Nettles R., Fowler V. G. Jr, Ryan T., Bashore T., Corey G. R. 2000; Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638 [CrossRef]
   [Google Scholar]
6. MacCallum D. M., Whyte J. A., Odds F. C. 2005; Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. Antimicrob Agents Chemother 49:3697–3701 [CrossRef]
   [Google Scholar]
7. Marr K. 2004; Combination antifungal therapy: where are we now and where are we going?. Oncology 18 (Suppl. 7):S24–S29
   [Google Scholar]
8. Maschmeyer G., Ruhnke M. 2004; Update on antifungal treatment of invasive Candida and Aspergillus infections. Mycoses 47:263–276 [CrossRef]
   [Google Scholar]
9. Muehrcke D. D., Lytle B. W., Cosgrove D. M. III 1995; Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis. Ann Thorac Surg 60:538–543 [CrossRef]
   [Google Scholar]
10. NCCLS 1998 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium-forming Filamentous Fungi: Proposed Standard . NCCLS document M38-P Wayne, PA: National Committee for Clinical Laboratory Standards;
    [Google Scholar]
11. Pierrotti L. C., Baddour L. M. 2002; Fungal endocarditis, 1995–2000. Chest 122:302–310 [CrossRef]
    [Google Scholar]
12. Rubinstein E., Noriega E. R., Simberkoff M. S., Rahal J. J. Jr (1974).Tissue penetration of amphotericin B in Candida endocarditis. Chest 66:376 [CrossRef]
    [Google Scholar]
13. Rubinstein E., Noriega E. R., Simberkoff M. S., Holzman R., Rahal J. J. Jr 1975; Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine 54:331–334
    [Google Scholar]